Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Chubb
Cipla
Medtronic
Novartis
UBS
Healthtrust
Covington
Farmers Insurance
Moodys

Generated: January 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 072034

« Back to Dashboard

NDA 072034 describes NITROGLYCERIN, which is a drug marketed by Hercon Pharm, Kremers Urban Pharms, Mylan Technologies, Abraxis Pharm, Hospira, Intl Medication, Luitpold, Smith And Nephew, Fougera Pharms Inc, Perrigo Israel, Actavis Labs Fl Inc, Dr Reddys Labs Inc, Glenmark Pharms Ltd, and Baxter Hlthcare, and is included in twenty-four NDAs. It is available from seventeen suppliers. Additional details are available on the NITROGLYCERIN profile page.

The generic ingredient in NITROGLYCERIN is nitroglycerin. There are thirty-six drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the nitroglycerin profile page.
Summary for 072034
Tradename:NITROGLYCERIN
Applicant:Luitpold
Ingredient:nitroglycerin
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 072034
Ingredient-typeNitrates
Physiological EffectVasodilation
Medical Subject Heading (MeSH) Categories for 072034
Suppliers and Packaging for NDA: 072034
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NITROGLYCERIN nitroglycerin INJECTABLE;INJECTION 072034 ANDA American Regent, Inc. 0517-4810 0517-4810-25 25 VIAL, SINGLE-DOSE in 1 TRAY (0517-4810-25) > 10 mL in 1 VIAL, SINGLE-DOSE
NITROGLYCERIN nitroglycerin INJECTABLE;INJECTION 072034 ANDA General Injectables and Vaccines, Inc. 52584-810 52584-810-25 1 VIAL in 1 BAG (52584-810-25) > 10 mL in 1 VIAL

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength5MG/ML
Approval Date:May 24, 1988TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fuji
UBS
Novartis
Citi
McKinsey
Chinese Patent Office
AstraZeneca
Moodys
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot